BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

806 related articles for article (PubMed ID: 29615514)

  • 1. Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor-stroma crosstalk.
    Orozco CA; Martinez-Bosch N; Guerrero PE; Vinaixa J; Dalotto-Moreno T; Iglesias M; Moreno M; Djurec M; Poirier F; Gabius HJ; Fernandez-Zapico ME; Hwang RF; Guerra C; Rabinovich GA; Navarro P
    Proc Natl Acad Sci U S A; 2018 Apr; 115(16):E3769-E3778. PubMed ID: 29615514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galectin-1 drives pancreatic carcinogenesis through stroma remodeling and Hedgehog signaling activation.
    Martínez-Bosch N; Fernández-Barrena MG; Moreno M; Ortiz-Zapater E; Munné-Collado J; Iglesias M; André S; Gabius HJ; Hwang RF; Poirier F; Navas C; Guerra C; Fernández-Zapico ME; Navarro P
    Cancer Res; 2014 Jul; 74(13):3512-24. PubMed ID: 24812270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galectin-3 Mediates Tumor Cell-Stroma Interactions by Activating Pancreatic Stellate Cells to Produce Cytokines via Integrin Signaling.
    Zhao W; Ajani JA; Sushovan G; Ochi N; Hwang R; Hafley M; Johnson RL; Bresalier RS; Logsdon CD; Zhang Z; Song S
    Gastroenterology; 2018 Apr; 154(5):1524-1537.e6. PubMed ID: 29274868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galectin-1-driven upregulation of SDF-1 in pancreatic stellate cells promotes pancreatic cancer metastasis.
    Qian D; Lu Z; Xu Q; Wu P; Tian L; Zhao L; Cai B; Yin J; Wu Y; Staveley-O'Carroll KF; Jiang K; Miao Y; Li G
    Cancer Lett; 2017 Jul; 397():43-51. PubMed ID: 28336327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of PAK1 suppresses pancreatic cancer by stimulation of anti-tumour immunity through down-regulation of PD-L1.
    Wang K; Zhan Y; Huynh N; Dumesny C; Wang X; Asadi K; Herrmann D; Timpson P; Yang Y; Walsh K; Baldwin GS; Nikfarjam M; He H
    Cancer Lett; 2020 Mar; 472():8-18. PubMed ID: 31857154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibiting YAP expression suppresses pancreatic cancer progression by disrupting tumor-stromal interactions.
    Jiang Z; Zhou C; Cheng L; Yan B; Chen K; Chen X; Zong L; Lei J; Duan W; Xu Q; Li X; Wang Z; Ma Q; Ma J
    J Exp Clin Cancer Res; 2018 Mar; 37(1):69. PubMed ID: 29587800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipocalin-2 Promotes Pancreatic Ductal Adenocarcinoma by Regulating Inflammation in the Tumor Microenvironment.
    Gomez-Chou SB; Swidnicka-Siergiejko AK; Badi N; Chavez-Tomar M; Lesinski GB; Bekaii-Saab T; Farren MR; Mace TA; Schmidt C; Liu Y; Deng D; Hwang RF; Zhou L; Moore T; Chatterjee D; Wang H; Leng X; Arlinghaus RB; Logsdon CD; Cruz-Monserrate Z
    Cancer Res; 2017 May; 77(10):2647-2660. PubMed ID: 28249896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrin α11 in pancreatic stellate cells regulates tumor stroma interaction in pancreatic cancer.
    Schnittert J; Bansal R; Mardhian DF; van Baarlen J; Östman A; Prakash J
    FASEB J; 2019 May; 33(5):6609-6621. PubMed ID: 30808244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galectin-1 secreted by activated stellate cells in pancreatic ductal adenocarcinoma stroma promotes proliferation and invasion of pancreatic cancer cells: an in vitro study on the microenvironment of pancreatic ductal adenocarcinoma.
    Xue X; Lu Z; Tang D; Yao J; An Y; Wu J; Li Q; Gao W; Xu Z; Qian Z; Dai C; Wei J; Miao Y; Jiang K
    Pancreas; 2011 Aug; 40(6):832-9. PubMed ID: 21747316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The critical roles of activated stellate cells-mediated paracrine signaling, metabolism and onco-immunology in pancreatic ductal adenocarcinoma.
    Fu Y; Liu S; Zeng S; Shen H
    Mol Cancer; 2018 Feb; 17(1):62. PubMed ID: 29458370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GM-CSF Mediates Mesenchymal-Epithelial Cross-talk in Pancreatic Cancer.
    Waghray M; Yalamanchili M; Dziubinski M; Zeinali M; Erkkinen M; Yang H; Schradle KA; Urs S; Pasca Di Magliano M; Welling TH; Palmbos PL; Abel EV; Sahai V; Nagrath S; Wang L; Simeone DM
    Cancer Discov; 2016 Aug; 6(8):886-99. PubMed ID: 27184426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage PI3Kγ Drives Pancreatic Ductal Adenocarcinoma Progression.
    Kaneda MM; Cappello P; Nguyen AV; Ralainirina N; Hardamon CR; Foubert P; Schmid MC; Sun P; Mose E; Bouvet M; Lowy AM; Valasek MA; Sasik R; Novelli F; Hirsch E; Varner JA
    Cancer Discov; 2016 Aug; 6(8):870-85. PubMed ID: 27179037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stromal architecture directs early dissemination in pancreatic ductal adenocarcinoma.
    Ray A; Callaway MK; Rodríguez-Merced NJ; Crampton AL; Carlson M; Emme KB; Ensminger EA; Kinne AA; Schrope JH; Rasmussen HR; Jiang H; DeNardo DG; Wood DK; Provenzano PP
    JCI Insight; 2022 Feb; 7(3):. PubMed ID: 34914633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Axon Guidance Molecules Promote Perineural Invasion and Metastasis of Orthotopic Pancreatic Tumors in Mice.
    Jurcak NR; Rucki AA; Muth S; Thompson E; Sharma R; Ding D; Zhu Q; Eshleman JR; Anders RA; Jaffee EM; Fujiwara K; Zheng L
    Gastroenterology; 2019 Sep; 157(3):838-850.e6. PubMed ID: 31163177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cav-1 Ablation in Pancreatic Stellate Cells Promotes Pancreatic Cancer Growth through Nrf2-Induced shh Signaling.
    Shao S; Qin T; Qian W; Li X; Li W; Han L; Zhang D; Wang Z; Ma Q; Wu Z; Wu E; Lei J
    Oxid Med Cell Longev; 2020; 2020():1868764. PubMed ID: 32377291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor Cell-Derived IL1β Promotes Desmoplasia and Immune Suppression in Pancreatic Cancer.
    Das S; Shapiro B; Vucic EA; Vogt S; Bar-Sagi D
    Cancer Res; 2020 Mar; 80(5):1088-1101. PubMed ID: 31915130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collagen type V promotes the malignant phenotype of pancreatic ductal adenocarcinoma.
    Berchtold S; Grünwald B; Krüger A; Reithmeier A; Hähl T; Cheng T; Feuchtinger A; Born D; Erkan M; Kleeff J; Esposito I
    Cancer Lett; 2015 Jan; 356(2 Pt B):721-32. PubMed ID: 25449434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic Stellate Cells Promote Tumor Progression by Promoting an Immunosuppressive Microenvironment in Murine Models of Pancreatic Cancer.
    Li C; Cui L; Yang L; Wang B; Zhuo Y; Zhang L; Wang X; Zhang Q; Zhang S
    Pancreas; 2020 Jan; 49(1):120-127. PubMed ID: 31856087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic cancer: the role of pancreatic stellate cells in tumor progression.
    Dunér S; Lopatko Lindman J; Ansari D; Gundewar C; Andersson R
    Pancreatology; 2010; 10(6):673-81. PubMed ID: 21242706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galectin-3 Released by Pancreatic Ductal Adenocarcinoma Suppresses γδ T Cell Proliferation but Not Their Cytotoxicity.
    Gonnermann D; Oberg HH; Lettau M; Peipp M; Bauerschlag D; Sebens S; Kabelitz D; Wesch D
    Front Immunol; 2020; 11():1328. PubMed ID: 32695112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.